Alkem Laboratories gets three observations from USFDA for Baddi plant

14 Mar 2017 Evaluate

The US Food and Drug Administration (USFDA) has issued a form 483 with three observations to Alkem Laboratories after an inspection at its facility in Himachal Pradesh, India. The US health regulator inspected the plant from March 2 to March 10 and has issued an inspection report to the company which contains three 483 observations. The company's plant in Baddi, manufactures finished formulations.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

5689.30 77.65 (1.38%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×